Shandong Weifang Rainbow Chemical Past Earnings Performance
Past criteria checks 1/6
Shandong Weifang Rainbow Chemical has been growing earnings at an average annual rate of 20.5%, while the Chemicals industry saw earnings growing at 7.8% annually. Revenues have been growing at an average rate of 13.6% per year. Shandong Weifang Rainbow Chemical's return on equity is 11.6%, and it has net margins of 6.2%.
Key information
20.5%
Earnings growth rate
14.1%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 13.6% |
| Return on equity | 11.6% |
| Net Margin | 6.2% |
| Next Earnings Update | 30 Aug 2024 |
Recent past performance updates
Recent updates
Take Care Before Diving Into The Deep End On Shandong Weifang Rainbow Chemical Co., Ltd (SZSE:301035)
Aug 07
Shandong Weifang Rainbow Chemical (SZSE:301035) Has A Somewhat Strained Balance Sheet
Jul 12Shandong Weifang Rainbow Chemical (SZSE:301035) Has More To Do To Multiply In Value Going Forward
Jun 21Why Shandong Weifang Rainbow Chemical's (SZSE:301035) Shaky Earnings Are Just The Beginning Of Its Problems
May 02Shandong Weifang Rainbow Chemical Co., Ltd's (SZSE:301035) Shares Not Telling The Full Story
Apr 04Revenue & Expenses Breakdown
How Shandong Weifang Rainbow Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 11,945 | 741 | 1,107 | 278 |
| 31 Dec 23 | 11,485 | 771 | 1,011 | 298 |
| 30 Sep 23 | 11,063 | 829 | 771 | 272 |
| 30 Jun 23 | 11,725 | 950 | 660 | 218 |
| 31 Mar 23 | 13,574 | 1,209 | 695 | 302 |
| 01 Jan 23 | 14,460 | 1,413 | 714 | 335 |
| 30 Sep 22 | 14,954 | 1,656 | 773 | 442 |
| 30 Jun 22 | 13,562 | 1,413 | 744 | 447 |
| 31 Mar 22 | 11,104 | 1,091 | 616 | 362 |
| 01 Jan 22 | 9,797 | 800 | 537 | 312 |
| 30 Sep 21 | 8,175 | 459 | 454 | 235 |
| 30 Jun 21 | 7,721 | 443 | 433 | 235 |
| 31 Mar 21 | 7,310 | 399 | 415 | 216 |
| 31 Dec 20 | 7,290 | 438 | 420 | 227 |
| 31 Dec 19 | 6,074 | 339 | 472 | 192 |
| 31 Dec 18 | 5,402 | 310 | 405 | 149 |
| 31 Dec 17 | 5,047 | 262 | 483 | 0 |
| 31 Dec 16 | 3,802 | 238 | 377 | 0 |
| 30 Sep 16 | 3,474 | 193 | 358 | 0 |
| 30 Jun 16 | 3,211 | 197 | 319 | 0 |
| 31 Mar 16 | 3,059 | 191 | 291 | 0 |
| 31 Dec 15 | 2,907 | 179 | 262 | 0 |
| 31 Dec 14 | 3,077 | 147 | 221 | 0 |
| 31 Dec 13 | 2,757 | 286 | 222 | 0 |
Quality Earnings: 301035 has a high level of non-cash earnings.
Growing Profit Margin: 301035's current net profit margins (6.2%) are lower than last year (8.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301035's earnings have grown significantly by 20.5% per year over the past 5 years.
Accelerating Growth: 301035's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 301035 had negative earnings growth (-38.7%) over the past year, making it difficult to compare to the Chemicals industry average (-14.6%).
Return on Equity
High ROE: 301035's Return on Equity (11.6%) is considered low.